Publications

5674 Results

Southwest Oncology Group study 9921: prolonged event free survival in high risk prostate cancer (PC) patients receiving adjuvant androgen deprivation

Authors
IM Thompson;CM Tangen;MHA Hussain;DP Wood;G Swanson;DI Quinn;TB Dorff;NA Dawson;NB Haas;ED Crawford;LM Glode
Journal / Conference
American Urological Association 2010 Meeting; late breaking; oral
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S9921

Cell cycle regulatory protein alterations in a randomized clinical trial of adjuvant chemotherapy following radical cystectomy and pelvic lymphadenectomy

Authors
SP Lerner;W Stadler;S Groshen;J Cai;A Mitra;E Tuazon;D Skinner;D Raghavan;D Esrig;G Steinberg;C Hall;RJ Cote
Journal / Conference
Journal of Urology 183(4):suppl.E662(abstr #1715); AUA 2010 Meeting (poster)
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
4B951

A phase II study to measure response rate and toxicity of neoadjuvant chemoradiotherapy with oxaliplatin (OX) and infusional 5-fluorouracil (5-fU) plus cetuximab followed by post-operative docetaxel cetuximab in patients with operable adenocarcinoma of the esophagus [E2205]

Authors
MK Gibson;L Kleinberg;C Staley;P Catalano;F Song;MF Mulcahy;LP Leichman;LB Benson
Journal / Conference
Journal of Clinical Oncology 28:7s(suppl;abstr 4064); poster presentation
Year
2010
Research Committee(s)
Gastrointestinal

Gene polymorphisms in cyclophosphamide metabolism pathway, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer [PMC3058716; PMID21169260]

Authors
S Yao;W Barlow;K Albain;JY Choi;H Zhao;R Livingston;W Davis;J Rae;IT Yeh;L Hutchins;P Ravdin;S Martino;A Lyss;CK Osborne;M Abeloff;G Hortobagyi;DF Hayes;C Ambrosone
Journal / Conference
Clinical Cancer Research 16:6169-6176;
Year
2010
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

Manganese superoxide dismutase polymorphism treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer [PMID 20309628; PMC2968705]

Authors
S Yao;W Barlow;K Albain;JY Choi;H Zhao;R Livingston;W Davis;J Rae;IT Yeh;L Hutchins;P Ravdin;S Martino;A Lyss;CK Osborne;M Abeloff;G Hortobagyi;DF Hayes;C Ambrosone
Journal / Conference
Breast Cancer Treatment and Research 124(2):433-439;
Year
2010
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced stage non-small cell lung cancer:Southwest Oncology Group study S0342

Authors
R Herbst;K Kelly;K Chanksy;PC Mack;W Franklin;F Hirsch;JN Atkins;S Dakhil;K Albain;E Kim;M Redman;J Crowley;D Gandara
Journal / Conference
Journal of Clinical Oncology 28(31):4747-4754;
Year
2010
Research Committee(s)
Lung
PMID
PMID20921467
PMC
PMC3020704
Study Number(s)
S0342

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set [PMC2815708; PMID20008641]

Authors
A de Gramont;J Hubbard;Q Shi;M O'Connell;M Buyse;J Benedetti;B Bott;C O'Callaghan;G Yothers;RM Goldberg;CD Blanke;A Benson;Q Deng;S Alberts;T Andre;N Wolmark;A Grothey;D Sargent
Journal / Conference
Journal of Clinical Oncology 28(3):460-465
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Association of intratumoral gene expression levels of TP (thymidine phosphorylase) and VEGF are associated with clinical outcome in stage II/III rectal cancer patients treated with 5-fluorouracil (5-FU) and pelvic radiation in a phase III intergroup trial (SWOG 9304)

Authors
R Ladner;C Ulrich;C Rankin;K Danenberg;P Danenberg;SR Smalley;KW Makar;J Benedetti;CD Blanke;HJ Lenz
Journal / Conference
Journal of Clinical Oncology 28:7s, 2010 (suppl; abstr 3640); ASCO Annual Meeting; poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Human papillomavirus types 16, 18 and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. PMC2820385; PMID: 20142255

Authors
S Sutcliffe;R Viscidi;C Till;P Goodman;A Hoque;A Hsing;IM Thompson;J Zenilman;A De Marzo;EA Platz
Journal / Conference
Cancer Epidemiology Biomarkers and Prevention 19(2):614-618
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Transparency and reproducibility in data analysis: The Prostate Cancer Prevention Trial. PMC2883301 PMID:20173101

Authors
S Baker;A Darke;P Pinsky;H Parnes;B Kramer
Journal / Conference
Biostatistics 11(3):413-418
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217